Invesco
ABOS icon

Invesco’s Acumen Pharmaceuticals ABOS Stock Holding History

Invesco’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$65.7K Buy
+24,588
New +$60.7K ﹤0.01% 3776
2025
Q2 		– Sell
-127,798
Closed -$141K – 3758
2025
Q1 		$141K Buy
127,798
+107,956
+544% +$154K ﹤0.01% 3584
2024
Q4 		$34.1K Buy
19,842
+1,653
+9% +$3.98K ﹤0.01% 3720
2024
Q3 		$45.1K Sell
18,189
-797
-4% -$2.16K ﹤0.01% 3696
2024
Q2 		$45.9K Buy
+18,986
New +$60.4K ﹤0.01% 3830

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $1.12B AUM 41.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Invesco's ABOS Position: Q2 2026 in Review

Invesco opened a new position in Acumen Pharmaceuticals (ABOS) in Q2 2026: 24,588 shares worth $65.7K. The stake represents ﹤0.01% of the portfolio and ranks #3776 among its holdings. This is a return to the name: Invesco previously reported a position in ABOS as recently as Q1 2025.

Invesco first reported a position in ABOS in Q2 2024 and has held it in 5 quarters since. The position peaked at $141K in Q1 2025. 96 funds tracked by Wall St. Rank hold ABOS as of Q2 2026.

  • Invesco held 24,588 shares of Acumen Pharmaceuticals worth $65.7K as of Q2 2026.
  • Acumen Pharmaceuticals was a new Invesco position in Q2 2026.
  • Acumen Pharmaceuticals made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3776 holding.
  • Invesco first reported a position in Acumen Pharmaceuticals in Q2 2024 and has held it in 5 quarters since.
  • Invesco's Acumen Pharmaceuticals position peaked at $141K in Q1 2025.
  • 96 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.